Skip to main content
Equibles

Vanguard Global Advisers, LLC

Position in CERS — Cerus Corp

CIK 1811242 MALVERN, PA
Back to CERS Full portfolio

Position in CERS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$382,137
+$183,168 QoQ
Shares Held
130,869
+19.7% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 186 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CERS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Vanguard Global Advisers, LLC holds $1,345,014,902 across 97 Medical Devices names. CERS ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 3,927,717 $356,401,040
2 SYK
Stryker Corp
 744,625 $234,437,735
3 MDT
Medtronic plc
 2,865,007 $224,129,497
4 BSX
Boston Scientific Corp
 3,337,790 $142,456,877
5 EW
Edwards Lifesciences Corp
 1,240,852 $112,247,471
6 GEHC
GE HealthCare Technologies Inc.
 981,943 $62,854,171
7 DXCM
Dexcom Inc
 833,079 $56,107,870
8 STE
STERIS plc
 211,869 $44,613,255

All Filings in CERS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $382,137 130,869
2026-03-31 $198,969 109,324